India Oligonucleotides Synthesis Market - Industry Trends and Forecast to 2030

PUBLISHED: August 1, 2023

PAGES: 86 Pages

DELIVERY TIME: Inquiry

ADD TO COMPARE

SELECT AN OPTION

List of Tables

India Oligonucleotides Synthesis Market is expected to reach USD 191.35 Million by 2030 from USD 108.91 Million in 2022, growing at a CAGR of 7.4% during the forecast period of 2023 to 2030.

Market Segmentation:

India Oligonucleotides Synthesis Market, By Type (Custom Oligos, Predesigned Oligos), By Product Type (Equipment's, Reagents, Consumables & Accessories), Synthesis Method (Solid Phase Oligo Synthesis Method and Liquid/Enzymatic Phase Oligo Synthesis Method), Application (Diagnostics, Therapeutics, Research, Agriculture, Food, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organization, Research & Academic Institutes, Forensic Labs), Distribution Channel (Direct Tender, Retail Sales and Others), Country (India)

Industry Trends and Forecast to 2030.

Overview of India Oligonucleotides Synthesis Market Dynamics

Driver
Rising use of oligonucleotide synthesis in various applications
Restrain
Competition from other emerging market players
Opportunity
Increased focus on government initiatives and R&D

Market Players:

Some of the key players operating in the India Oligonucleotides Synthesis market are:

Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Merck KGaA
DH Life Sciences, LLC.
LGC Limited
Eurofins Genomics
GE HealthCare
METTLER TOLEDO
TriLink BioTechnologies
Ajinomoto Bio-Pharma.

1 INTRODUCTION 10

1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET DEFINITION 10
1.3 OVERVIEW OF THE INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET 10
1.4 LIMITATIONS 11
1.5 MARKETS COVERED 12

2 MARKET SEGMENTATION 14

2.1 MARKETS COVERED 14
2.2 GEOGRAPHICAL SCOPE 15
2.3 YEARS CONSIDERED FOR THE STUDY 15
2.4 CURRENCY AND PRICING 15
2.5 DBMR TRIPOD DATA VALIDATION MODEL 16
2.6 MULTIVARIATE MODELLING 19
2.7 PRODUCT TYPE LIFELINE CURVE 19
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 20
2.9 DBMR MARKET POSITION GRID 21
2.10 MARKET END USER COVERAGE GRID 22
2.11 VENDOR SHARE ANALYSIS 23
2.12 SECONDARY SOURCES 24
2.13 ASSUMPTIONS 24

3 EXECUTIVE SUMMARY 25

4 PREMIUM INSIGHTS 27

4.1 PESTEL ANALYSIS 28
4.2 PORTER'S FIVE FORCES 29
4.3 PRICING STRATEGY 30
4.4 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, CONJOINT ANALYSIS 31
- 4.4.1 FEATURE- CUSTOMIZATION 31
- 4.4.2 FEATURE- ADDITIONAL SERVICES 32

5 REGULATORY COMPLIANCE 33

5.1 REGULATORY AUTHORITIES: 33
5.2 REGULATORY SCENARIO IN INDIA - 33

6 MARKET OVERVIEW 35

6.1 DRIVERS 37
- 6.1.1 USE OF SYNTHESIZED OLIGONUCLEOTIDES IN VARIOUS APPLICATIONS 37
- 6.1.2 INCREASING GOVERNMENT INVESTMENTS AND R&D EXPENDITURE 37
6.2 RESTRAINTS 38
- 6.2.1 RISING COMPETITION AMONG MARKET PLAYERS 38
- 6.2.2 LACK OF TRAINED PROFESSIONALS 38
6.3 OPPORTUNITY 39
- 6.3.1 RISING TECHNOLOGICAL ADVANCEMENTS 39
6.4 CHALLENGE 39
- 6.4.1 LIMITATION OF OLIGONUCLEOTIDES SYNTHESIS 39

7 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE 40

7.1 OVERVIEW 41
7.2 CUSTOM OLIGOS 42
7.3 PREDESIGNED OLIGOS 42

8 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY PRODUCT TYPE 43

8.1 OVERVIEW 44
8.2 EQUIPMENT'S 45
- 8.2.1 OLIGOSYNTHESIZER 45
  - 8.2.1.1 SMALL SCALE SYNTHESIS 46
  - 8.2.1.2 MEDIUM SCALE SYNTHESIS 46
  - 8.2.1.3 LARGE SCALE SYNTHESIS 46
- 8.2.2 COMPUTER-CONTROLLED INSTRUMENTS 46
  - 8.2.2.1 COLUMN FORMAT 46
  - 8.2.2.2 MULTI-WELL PLATE FORMAT 46
8.3 REAGENTS, CONSUMABLES & ACCESSORIES 47
- 8.3.1 CAPPING REAGENTS 47
- 8.3.2 ACTIVATOR SOLUTION 48
  - 8.3.2.1 ACTIVATOR SOLUTION (DCI) 48
  - 8.3.2.2 ACTIVATOR SOLUTION (ETT) 48
  - 8.3.2.3 ACTIVATOR SOLUTION (BTT) 48
  - 8.3.2.4 OTHERS 48
- 8.3.3 OXIDIZER 49
- 8.3.4 DEBLOCK SOLUTION 49
  - 8.3.4.1 DEBLOCK DCM SOLUTION 49
  - 8.3.4.2 DEBLOCK DCE SOLUTION 49
- 8.3.5 COUPLING 50
  - 8.3.5.1 ANHYDROUS ACETONITRILE 50
  - 8.3.5.2 ACTIVATORS 50
- 8.3.6 DEPROTECTED REAGENTS 50
- 8.3.7 OTHERS 50

9 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY SYNTHESIS METHOD 51

9.1 OVERVIEW 52
9.2 SOLID PHASE OLIGO SYNTHESIS METHOD 53
- 9.2.1 COLUMN-BASED OLIGONUCLEOTIDE SYNTHESIS 53
- 9.2.2 MICROARRAY-BASED OLIGONUCLEOTIDE SYNTHESIS 53
9.3 LIQUID/ENZYMATIC PHASE OLIGO SYNTHESIS METHOD 54
- 9.3.1 TEMPLATE INDEPENDENT POLYMERASE-BASED METHOD 54
- 9.3.2 TEMPLATE-DEPENDENT POLYMERASE MEDIATED OLIGO SYNTHESIS 54

10 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY APPLICATION 55

10.1 OVERVIEW 56
10.2 DIAGNOSTICS 57
- 10.2.1 INFECTIOUS DISEASES 57
- 10.2.2 CANCER 57
- 10.2.3 NEUROLOGICAL DISEASE 58
- 10.2.4 CARDIOVASCULAR DISEASE 58
- 10.2.5 OTHERS 58
10.3 THERAPEUTICS 58
- 10.3.1 RNAI OLIGONUCLEOTIDE-BASED THERAPIES 58
- 10.3.2 DNA/ANTISENSE OLIGONUCLEOTIDE-BASED THERAPIES 58
- 10.3.3 IMMUNOTHERAPY (CPG OLIGONUCLEOTIDE-BASED THERAPIES) 59
- 10.3.4 NUCLEIC ACID APTAMERS 59
10.4 RESEARCH 59
- 10.4.1 APTAMER DESIGN 59
- 10.4.2 ALLELE-SPECIFIC TESTING 59
- 10.4.3 TRIPLEX-FORMING OLIGONUCLEOTIDES 59
- 10.4.4 OTHER RESEARCH APPLICATIONS 59
10.5 AGRICULTURE 60
10.6 FOOD 60
10.7 OTHERS 60

11 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY END USER 61

11.1 OVERVIEW 62
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 63
11.3 DIAGNOSTIC CENTERS 63
11.4 CONTRACT RESEARCH ORGANIZATION 63
11.5 RESEARCH & ACADEMIC INSTITUTES 63
11.6 FORENSIC LABS 63

12 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL 64

12.1 OVERVIEW 65
12.2 DIRECT TENDER 66
12.3 RETAIL SALES 66
12.4 OTHERS 66

13 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, COMPANY LANDSCAPE 67

13.1 COMPANY SHARE ANALYSIS: INDIA 67

14 COMPANY PROFILE 68

14.1 THERMO FISHER SCIENTIFIC 68
- 14.1.1 COMPANY SNAPSHOT 68
- 14.1.2 REVENUE ANALYSIS 68
- 14.1.3 PRODUCT PORTFOLIO 69
- 14.1.4 RECENT DEVELOPMENTS 69
14.2 AGILENT TECHNOLOGIES INC 70
- 14.2.1 COMPANY SNAPSHOT 70
- 14.2.2 REVENUE ANALYSIS 70
- 14.2.3 PRODUCT PORTFOLIO 71
- 14.2.4 RECENT DEVELOPMENTS 71
14.3 MERCK KGAA 72
- 14.3.1 COMPANY SNAPSHOT 72
- 14.3.2 REVENUE ANALYSIS 72
- 14.3.3 PRODUCT PORTFOLIO 73
- 14.3.4 RECENT DEVELOPMENT 73
14.4 DANAHER 74
- 14.4.1 COMPANY SNAPSHOT 74
- 14.4.2 REVENUE ANALYSIS 74
- 14.4.3 PRODUCT PORTFOLIO 75
- 14.4.4 RECENT DEVELOPMENT 75
14.5 LGC LIMITED 76
- 14.5.1 COMPANY SNAPSHOT 76
- 14.5.2 PRODUCT PORTFOLIO 76
- 14.5.3 RECENT DEVELOPMENT 76
14.6 AJINOMOTO BIO-PHARMA 77
- 14.6.1 COMPANY SNAPSHOT 77
- 14.6.2 PRODUCT PORTFOLIO 77
- 14.6.3 RECENT DEVELOPMENT 77
14.7 EUROFINS GENOMICS 78
- 14.7.1 COMPANY SNAPSHOT 78
- 14.7.2 PRODUCT PORTFOLIO 78
- 14.7.3 RECENT DEVELOPMENT 78
14.8 GENERAL ELECTRIC 79
- 14.8.1 COMPANY SNAPSHOT 79
- 14.8.2 REVENUE ANALYSIS 79
- 14.8.3 PRODUCT PORTFOLIO 80
- 14.8.4 RECENT DEVELOPMENT 80
14.9 METTLER TOLEDO INDIA PRIVATE LTD 81
- 14.9.1 COMPANY SNAPSHOT 81
- 14.9.2 PRODUCT PORTFOLIO 81
- 14.9.3 RECENT DEVELOPMENT 81
14.10 TRILINK BIOTECHNOLOGIES, LLC 82
- 14.10.1 COMPANY SNAPSHOT 82
- 14.10.2 PRODUCT PORTFOLIO 82
- 14.10.3 RECENT DEVELOPMENT 82

15 QUESTIONNAIRE 83

16 RELATED REPORTS 86

LIST OF TABLES

TABLE 1 THE AVERAGE COST OF OLIGONUCLEOTIDES SYNTHESIS IN INDIA: 30
TABLE 2 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 42
TABLE 3 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 45
TABLE 4 INDIA EQUIPMENT'S IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 45
TABLE 5 INDIA OLIGOSYNTHESIZER IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 45
TABLE 6 INDIA COMPUTER-CONTROLLED INSTRUMENTS IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 46
TABLE 7 INDIA REAGENTS, CONSUMABLES & ACCESSORIES IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 47
TABLE 8 INDIA ACTIVATOR SOLUTION IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 48
TABLE 9 INDIA DEBLOCK SOLUTION IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 49
TABLE 10 INDIA COUPLING IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 50
TABLE 11 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY SYNTHESIS METHOD, 2021-2030 (USD MILLION) 53
TABLE 12 INDIA SOLID PHASE OLIGO SYNTHESIS METHOD IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 53
TABLE 13 INDIA LIQUID/ENZYMATIC PHASE OLIGO SYNTHESIS METHOD IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 54
TABLE 14 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 57
TABLE 15 INDIA DIAGNOSTICS IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 57
TABLE 16 INDIA THERAPEUTICS IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 58
TABLE 17 INDIA RESEARCH IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION) 59
TABLE 18 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY END USER, 2021-2030 (USD MILLION) 63
TABLE 19 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 66

LIST OF FIGURES

FIGURE 1 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: SEGMENTATION 14
FIGURE 2 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: DATA TRIANGULATION 16
FIGURE 3 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: DROC ANALYSIS 17
FIGURE 4 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 18
FIGURE 5 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: COMPANY RESEARCH ANALYSIS 18
FIGURE 6 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: INTERVIEW DEMOGRAPHICS 20
FIGURE 7 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: DBMR MARKET POSITION GRID 21
FIGURE 8 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: MARKET END USER COVERAGE GRID 22
FIGURE 9 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: VENDOR SHARE ANALYSIS 23
FIGURE 10 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: SEGMENTATION 26
FIGURE 11 INCREASING APPLICATION OF OLIGONUCLEOTIDES SYNTHESIS IS EXPECTED TO DRIVE THE GROWTH OF THE INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET IN THE FORECAST PERIOD 27
FIGURE 12 THE CUSTOM OLIGOS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET IN 2023 AND 2030 27
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET 36
FIGURE 14 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: BY TYPE, 2022 41
FIGURE 15 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: BY PRODUCT TYPE, 2022 44
FIGURE 16 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: BY SYNTHESIS METHOD, 2022 52
FIGURE 17 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: BY APPLICATION, 2022 56
FIGURE 18 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: BY END USER, 2022 62
FIGURE 19 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2022 65
FIGURE 20 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: COMPANY SHARE 2022 (%) 67